U.S. Department of Health and Human Services
Beena Akolkar
 

 Contact Info

 
Tel: +1 301 594 8812
Email: akolkarb@mail.nih.gov
 

 Select Experience

 

Assistant Professor, Department of Medicine, Cornell University Medical College, North Shore University Hospital, 1996-2000

Instructor, Department of Medicine, Cornell University Medical College, North Shore University Hospital, 1995-1996

Instructor, Department of Medicine, Cornell University Medical College, North Shore University Hospital, 1992-1995

Research Associate, Department of Medicine, Cornell University Medical College, North Shore University Hospital, 1989-1992

Research Associate, Department of Microbiology and Biotechnology Centre, University of Baroda, Baroda, India, 1987-1989

Beena Akolkar, Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities and Activities

I am the senior advisor for the Diabetes Genetics and Genomics program.  My portfolio includes basic and clinical research on the genetics, immunopathogenesis, prevention, and treatment of type 1 diabetes (T1D).

I am the project scientist for the Environmental Determinants of Diabetes in the Young (TEDDY) study, an international consortium established with the goal of developing and carrying out studies to identify environmental triggers of T1D, such as infectious agents, dietary factors, and/or psychosocial factors, in genetically susceptible individuals.

I am the program director for the Type 2 Diabetes Multiethnic Genetic Consortium (T2D-GENES).

I also serve as a project officer for the NIDDK Central Repositories.  My responsibilities also include coordinating research activities on autoimmunity and transplant across the Division and T1D across the NIH.

​Research Programs

Clinical Research in Type 1 Diabetes
This program supports clinical research that addresses the determinants, etiology, progression, prevention, and treatment of type 1 diabetes in children and adults

Diabetes Genetics and Genomics
This program advances research to identify the genetic mechanisms underlying type 1 and type 2 diabetes—and how genetic and epigenetic variation influences the metabolism of therapeutics—with an aim towards developing better treatments

Diabetes: Treatment, Prevention, and Complications
This program supports both basic and clinical studies aimed at addressing the prevention, treatment, and pathophysiology of hypoglycemia and diabetes

Committee Membership

Type 1 Diabetes Working Group, Chair

Clinical Sciences Working Group, Member

Human Microbiome Project Group, Representative

Large Grants Committee, Member

Translation Working Group, Member​

NIDDK Clinical Sciences Working Group, Member

Genomics Working Group, Member

TrialNet, Ancillary, Laboratory, and Mechanistic Committees, Representative

Immune Tolerance Network Steering and Executive Committee, Member

Autoimmunity Centers of Excellence Steering Committee, Representative

CSGADP Steering Committee, Member

Autoimmunity/Transplant Working Group, Chair

TRIGR Steering Committee, Member